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In spite of the impressive progress in the investigation of hepatic encephalopathy (HE), the complex mechanisms underlying the
onsetanddeteriorationofHEarestillnotfullyunderstood.Currently,noneoftheexistingtheoriesprovideconclusiveexplanations
on the symptoms that link liver dysfunction to nervous system disorders and clinical manifestations. This paper summarized the
diagnostic and therapeutic approaches used for HE in modern medicine and traditional Chinese medicine and provided future
perspective in HE therapies from the viewpoint of holistic and personalized Chinese medicine.
1.Introduction
Hepatic encephalopathy (HE), also known as portosystemic
encephalopathy, is deﬁned as a spectrum of neuropsychiatric
abnormalities in patients with liver dysfunction, after exclu-
sion of other known brain diseases [1–3]. The aggravation
of HE will result in hepatic coma or coma hepaticum,
w h i c hm a yu l t i m a t e l yl e a dt od e a t h[ 4]. It is believed that
the increase of harmful substances entering brain from
blood is the main cause of HE, and currently the identiﬁed
causal factors for HE are ammonia [5, 6], γ-aminobutyric
acid (GABA) [7, 8], false neurotransmitters [9, 10], and
the imbalance of certain amino acids in plasma [11, 12].
In spite of the impressive progress in research aiming
to uncover the etiology of HE, the complex mechanisms
underlying the onset and deterioration of HE and related
conditions are still not fully understood. Currently, none
of the existing theories provide conclusive explanations on
the symptoms that link liver dysfunction to nervous system
disorders and clinical manifestations. Generally, it has been
accepted that high blood ammonia, which is not properly
metabolizedinandremovedfromliverbecauseofthehepatic
dysfunction, is closely associated with dysregulation of
central nervous system (CNS). The elevation of neurotoxins
such as ammonia in blood and CNS impairs the related
neurotransmitter system and leads to the functional disorder
of CNS. Such a complicated pathology of HE implies the
possibility of systematic involvement of multiple organs
in orchestrating the development of HE. Therefore, it is
necessary to adopt a systems strategy with interdisciplinary
studies to understand how dysregulated metabolites disturb
the organ-organ (liver-brain) interactions and eventually to
uncover the mechanisms of HE at a systems level.
Traditional Chinese medicine (TCM) typically involves
a personalized diagnosis and the use of herbal formulae
of between 10–20 separate herbal ingredients selected from
material medica of several thousand herbs that are prepared
either as a boiled decoction, as dried herbal extracts, or
taken as pills [13]. Diagnostic and therapeutic treatment
principles are framed according to the TCM understanding
of pathological processes. A good practice of TCM is
usually considered to require a TCM pattern identiﬁcation
based on clinical manifestation followed by the use of
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the particular TCM pattern of each patient [14]. Since the
treatment will change following the changing TCM patterns
and clinical manifestations. TCM is a dynamic and highly
responsive system of medicine that resonates strongly with
the increasing emphasis within systems biology strategy for
the use of both multiple approaches to achieve optimum
diagnosis and individualized treatments to take into account
variable responses to modern drugs.
In the theory of TCM, the onset of HE is due to the
invasion of damp and heat in triple burners which leads
to phlegm and stagnation of Qi, which eventually causes
the disability of thinking in HE patients. Such a traditional
theory appears to be consistent with the modern theories
of HE etiology. Given the holistic and personalized nature
of TCM, HE and its clinical manifestations are divided into
various TCM patterns (phenotypes) with diﬀerent char-
acteristics, which necessitate diﬀerent therapeutic methods
in TCM. In this paper, we summarized the theories and
therapeutic methods of HE both in modern medicine and
TCM and provided future perspective in HE therapies from
the viewpoint of systems biology.
2. The Diagnosisof HEin Modern Medicine
Todate,therearenogold-standarddiagnosticproceduresfor
HE with high sensitivity and speciﬁcity in modern medicine.
HE patients usually have advanced chronic liver disease and
thus have many of the physical and laboratory stigmata asso-
ciated with severe hepatic dysfunction. Physical features may
include muscle wasting, jaundice, ascites, palmar erythema,
edema, spider telangiectasias, and fetor hepaticus [15, 16].
However, some of these features (such as muscle wasting,
spider telangiectasias, and palmar erythema) are usually
absent in HE patients with fulminant hepatic failure who are
previouslyhealthy,becausethedevelopmentofthesefeatures
requires a relatively longer period of hepatic dysfunction. As
a result, substantial technical and laboratory examinations
are needed for diagnosis of HE patients, which include
psychological test, electrophysiological test, and imaging.
2.1. Psychological Test. The most common tests used in
clinics are number connection test (NCT), line tracking
test (LTT), serial dotting test (SDT), continuous reaction
time (CRT), critical frequency scintillometer (CFS), and
wisconsin Ccard sorting test (WCST). The combination of
these tests will increase the accuracy of HE determination,
avoiding false diagnosis based on a single test. For example,
HE psychological testing, a combined test group including
NCT, DST, LTT and SDT, has become a rapid and practical
procedure that takes less than 20 minutes and achieves 96%
sensitivity and 100% speciﬁcity.
2.2. Electrophysiological Test. Electrophysiological and elec-
tropsychological changes can be tested by electroencephalo-
gram (EEG) and brain electrical activity mapping (BEAM).
EEG can be used not only as an evaluation tool but for
early diagnosis as well. However, it may be diﬃcult to
evaluate the disease objectively as it lacks speciﬁcity [17].
Recently, based on the EEG assessment, a test called artiﬁcial
neural network-expert system (ANNES) with the computer
analysis technology is proposed as an expert system to
overcome this problem [18]. Additionally, analysis of the
EEG utilizing a spatiotemporal decomposition technique
(SEDACA) provides signiﬁcantly more diagnostic informa-
tion on the neuropsychiatric status of HE patients than
obtained conventionally [19].
2.3. Imaging. The imaging methods for HE include comput-
erized tomography (CT) and magnetic resonance imaging
(MRI), magnetic resonance spectroscopy (MRS), single pho-
ton emission computed tomography (SPECT), and positron
emission tomography (PET) [20]. CT and MRI are mainly
used to detect brain morphology, such as hydrocephalus
in the acute HE patients and encephalatrophy, especially
in lobus frontalis in the chronic HE patients [21]. MRS is
mainly used to detect the changes of compounds in cells,
analyzing the concentrations of such metabolites as gly-
coconjugates, amino acids, cholines, phospholipids, and
creatine to help early diagnosis. Both SPECT and PET are
used extensively to assess brain perfusion, which is typically
less “active” in HE patients than in healthy people.
3. Therapies of HE in Modern Medicine
The treatments for HE typically include (1) elimination or
correction of the underlying factors participating in HE,
(2) restoring metabolic homeostasis, (3) promoting regen-
eration of liver cells, (4) antibiotic agents that inhibit
mucosal glutaminase in the intestine to reduce ammonia
production in the gut, and (5) artiﬁcial liver support or liver
transplantation [22–26]. Most patients show clinical signs of
improvement in the symptoms of HE within 24–48 hours of
initiation of treatment. Serum levels of ammonia might lag
behind the clinical response.
3.1.DietaryRegulationofHomeostasis. Restrictionofprotein
intake in diet is preferred for HE therapy. It is advised to
consume more calories from vegetable and dairy protein,
because vegetable protein is rich in branched-chain amino
acids and nonabsorbent ﬁber, which are beneﬁcial for
the balance of normal gut microbiota and acidifying the
intestinal tract. It is also necessary to uptake suﬃcient
carbohydrate and vitamins, that is, vitamin C can reduce the
levelofpHinbloodanddivertammoniafrombraintoblood
[27–29]. On the other hand, drinking suﬃcient water is
helpful for maintaining homeostasis of the body, which pro-
tects body from hypokalemia, hyperkalemia, hyponatremia,
hypocalcemia, hypomagnesemia, and metabolic alkalosis.
Additionally, some other ways are available for keeping
the homeostasis such as plasma or albumin transfusion, to
increase plasma colloid osmotic pressure, improve hypox-
emia and hydrocephalus, and prevent hemorrhage and
bacterial infection.
3.2. Elimination of Blood Ammonia. Elimination of blood
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used as a standard medicine to evaluate the eﬀect of new
d r u gf o rH E[ 30]. Besides, Lactitol is also well practiced for
HE therapy with comparable eﬀect to lactulose, but with
better tolerance [31, 32]. Although Neomycin is eﬀective for
HE patients, long-term usage is prohibited for its toxicity
[33, 34]. Oral administration of L-7-ornithine-aspartate
(OA) can eﬀectively eliminate the level of blood ammonia
[35]. Recent studies show that the concentration of blood
ammonia in HE patients was signiﬁcantly decreased by
Rifaximin, as well as amelioration of the patients’ condition
[36–38].
3.3. Supplementation of Branched-Chain Amino Acids. The
administrationofbranched-chainaminoacids(BCAAs)may
help adjust the abnormal ratio of BCAAs to aromatic amino
acids (AAAs) crossing the blood-brain barrier (BBB), so that
the symptom of HE can be improved. A recent meta-analysis
has shown that patients with cirrhosis who receive BCAAs
are more likely to recover from HE than those who do not
receivethis supplement [39].BCAAs improve levels ofserum
albumin, increase progression-free survival, and reduce both
the number of hospitalizations and the length of hospital
stays in patients with cirrhosis [40]. These amino acids can
be administered orally as well as intravenously.
3.4. Use of False Neurotransmitter Antagonist. According to
the theory of false neurotransmitter for HE development
[2, 10], antagonists of false neurotransmitter could be
used for HE therapy, including bendopa, dopamine agonist
Bromocriptine, and opium receptor Narcon. Bendopa could
pass the BBB and ﬂow into brain tissue and produce
dopamine and norepinephrine by enzymatic catalysis, which
are substitutes for the false neurotransmitter and help to
recover nerve function. Bromocriptine could agitate postsy-
naptic dopamine receptor to upregulate prolactin with nerve
transmitting function strengthened. Using Bromocriptine
alone or with Lactulose together is especially eﬀective to
those chronic HE patients who are insensitive to Neomycin
or Lactulose. Narcon can cross BBB easily and attenuate
the inhibited eﬀect on CNS caused by redundant opioid
peptides. Clinical data showed that Narcon is helpful
to improve the consciousness of HE patients. However,
evidence has indicated that obvious variations exist in
therapeutic eﬀectiveness of these medicines on HE patients
[41, 42].
4. Treatment of HE in TCM
In TCM, the phenotype of HE is the result of impaired
resistance to damp and heat environment (two of the six
exogenous pathogens in TCM including wind, cold, heat,
damp, dryness, and ﬁre), along with the reduced function
of middle burner (the middle part of triple burners in TCM,
referring mainly to the organs located between diaphragm
and navel, including stomach and spleen) to excrete toxic
substances. The accumulated toxic substances in the middle
burnerspreadtothetripleburners(including upper,middle,
and lower burner, covering all of the organs) and aﬀect
the upper oriﬁces (upper oriﬁces are the openings on the
face, such as the eyes, ears, nose, and mouth). The essential
substances of the organs are distributed through these ori-
ﬁces,soanypathologicchangeoftheseoriﬁcescontributesto
adiagnosisofthedisordersoftheseorgans.Thepathogenesis
in TCM view is consistent with the modern medicine in
that abnormal accumulation of metabolites, especially the
production, absorption, and distribution of endotoxin in the
patients with liver failure will cause the metabolic imbalance
in blood. As a result, the therapeutic strategy for HE under
TCM includes purgation and eliminating stasis in organs
and inducing resuscitation, which is holistic and dynamic in
nature.
4.1. Treatment of HE according to TCM Patterns. TCM pat-
tern diﬀerentiation is a method to analyze and characterize
theclinical manifestations ofadisease,aprocessinwhichthe
geographical location, nature, occurrence, and development
ofthediseasedandpathogenicfactorsaretakenintoaccount.
Once a speciﬁc pattern of an HE patient is identiﬁed, a
speciﬁc treatment strategy will be used to correct or mitigate
the pattern of the patient. Table 1 provides a summary of
typicalTCMpatternsofHEandtheirsubsequenttreatments.
4.1.1. TCM Pattern of HE—Invasion of Pericardium by
Excessive Heat Toxin. The main clinical manifestation of
this pattern is characterized as follows. High fever appears
at night, severe jaundice with clear yellowing of the body
and deteriorating fast, either coma and unconsciousness
or disturbed emotion even delirium, constipation inducing
distension and ascites, hemorrhinia, hematemesis, hema-
tochezia, bright red tongue substance with yellow and dry
tongue coating, taut thready or taut rapid pulse. Treatment
should be cleansing the heat toxin and inducing resus-
citation. TCM prescriptions commonly used in clinic are
Purple Snowy Powder [43], Qing Ying Liang Xue Tang and
Cow-bezoar Bolus for Resurrection [44], Antipyretic and
Antitoxic Decoction [45], Coptidis Decoction for Detoxiﬁ-
cation, combined with Rhubarb and Treasured Bolus [46],
and a new prescription made with some of the herbs
from the three prescriptions Herbae Artemisiae Capillariae
Decoction, Antiphlogistic Decoction of Five Drugs, and
Cornus Rhinoceri and Rehmannia Decoction [45].
4.1.2. TCM Pattern of HE—Dampness and Phlegm Accumu-
lationCausingMentalConfusion. Themainclinical manifes-
tation of this syndrome is characterized as follows. Apparent
symptom of jaundice, dark complexion, coma with nausea
and vomiting, abdominal distension, high fever at the same
time, urine with yellow color and small amount, exhaustion,
chest distress, abdominal ﬂatulence, bitterness in the mouth,
dark red tongue substance with white greasy or yellow
greasy tongue coating, soft and rolling pulse or soft and
thready pulse. Treatment should be clearing away dampness,
dispelling Phlegm and inducing resuscitation. TCM pre-
scriptions commonly used in clinics are Herbae Artemisiae
Capillariae Decoction [47], Artemisiae Scopariae and Poriae
Powder [48], Phlegm-removing decoction, combined with4 Evidence-Based Complementary and Alternative Medicine
Table 1: The typing, prescription, and treatments for diﬀerent syndromes of HE.
Prescription Medicinal herb ingredients
Invasion of pericardiuma by excessive heat and toxin
Zi Xue Pill
Gypsum Fibrosum, Gypsum Rubrum, Magnetitum, Talcum, Bubali
Cornu, Saigae Tataricae Cornu, Aucklandiae Radix, Aquilariae Lignum
Resinatum, Cimicifugae Rhizoma, Glycyrrhizae Radix et Rhizoma,
Caryophylli Flos, Natrii Sulfas, Moschus, Cinnabaris
Qing Ying Liang Xue Decoction
Bubali Cornu, Salviae Miltiorrhizae Radix et Rhizoma, Artemisiae
Scopariae Herba,
An Gong Niu Huang Pill
Imperatae Rhizoma, Bergenia Herba, Paeoniae Radix Rubra,
Rehmanniae Radix, Moutan Cortex, Gardeniae Fructus Praeparatus,
Rhei Radix et Rhizoma
Qing Wen Bai Du Oral Solution
Bubali Cornu, Coptidis Rhizoma, Scutellariae Radix, Artemisiae
Scopariae Herba, Lysimachiae Herba, Gypsum Fibrosum,
Anemarrhenae Rhizoma, Platycodonis Radix, Rhei Radix et Rhizoma,
Gardeniae Fructus, Smilacis Glabrae Rhizoma, Alismatis Rhizoma,
Plantaginis Semen, Aurantii Fructus Immaturus, Forsythiae Fructus,
Rehmanniae Radix, Lophatheri Herba, Scrophulariae Radix
Huang Lian Decoction for Detoxiﬁcation
Plus Zhi Bao Pill
Coptidis Rhizoma, Phellodendri Chinensis Cortex, Scutellariae Radix,
Gardeniae Fructus, Rhei Radix et Rhizoma
Bubali Cornu, Bovis Calculus, Eretmochelys imbricata, Ambrum,
Cinnabaris, Realgar, Moschus, Benzoinum
Yin Chen Hao Decoction Artemisiae Scopariae Herba, Gardeniae Fructus, Rhei Radix et Rhizoma
Wu Wei Detoxiﬁcation Oral Liquid
Lonicerae Japonicae Flos, Taraxaci Herba, Violae Herba, Begonia
Fimbristipula Herba, Eupolyphaga or Steleophaga
Xi Jiao Di Huang Decoction
Bubali Cornu, Rehmanniae Radix, Paeoniae Radix Rubra, Moutan
Cortex, Arnebiae Radix
Pattern of mental confusion by dampness and phlegmb accumulation
Yin Chen Wu Ling Dispersing agent
Artemisiae Scopariae Herba, Polyporus, Alismatis Rhizoma,
Atractylodis Macrocephalae Rhizoma, Poria, Cinnamomi Ramulus
Phlegm-removing Decoction with Da
Huang
Arisaematis Rhizoma, Pinelliae Rhizoma, Aurantii Fructus Immaturus
Poria, Citri Exocarpium Rubrum, Cinnabaris, Acori Tatarinowii
Rhizoma, Atractylodis Macrocephalae Rhizoma, Caryophylli Flos,
Aquilariae Lignum Resinatum, Santalum album,
Su He Xiang Pill
Olibanum, Piperis Longi Fructus, Bubali Cornu, Benzoinum,
Aucklandiae Radix, Cyperi Rhizoma, GinsengRadix et Rhizoma,
Bambusae Caulis In Taenias, Glycyrrhizae Radix et Rhizoma, Rhei
Radix et Rhizoma, Styrax, Moschus, Borneolum Syntheticum
Ju Fang Zhi Bao Pill
Bubali Cornu, Bovis Calculus, Eretmochelys imbricata, Ambrum,
Cinnabaris, Realgar, Moschus, Benzoinum
Yin Chen Si Ling Decoction
Artemisiae Scopariae Herba, Poria, Alismatis Rhizoma, Polyporus,
Gardeniae Fructus
Chang Pu Yu Jin Decoction
Acori Tatarinowii Rhizoma, Curcumae Radix, Arisaema Cum Bile,
Pinelliae Rhizoma, Magnoliae Oﬃcinalis Cortex, Myristicae Semen,
Polygalae Radix, Forsythiae Fructus, Pogostemonis Herba
Pattern of Yinc deﬁciency of liver and kidney and Yangc excess of Liver
Yi Guan Decoction
Rehmanniae Radix, Angelicae Sinensis Radix, Lycii Fructus, Glehniae
Radix, Ophiopogonis Radix, Toosendan FructusEvidence-Based Complementary and Alternative Medicine 5
Table 1: Continued.
Prescription Medicinal herb ingredients
Ling Yang Jiao Decoction
Saigae Tataricae Cornu, Testudinis Carapax Et Plastrum, Rehmanniae
Radix, Ligustri Lucidi Fructus, Eclipse Prostrala Herba, Dendrobii
Caulis, Margaritifera Concha, Moutan Cortex, Paeoniae Radix Rubra,
Bupleuri Radix, Prunellae Spica, Chrysanthemi Flos, Haliotidis
Concha, Carthami Flos, Persicae Semen, Angelicae Sinensis Radix,
Chuanxiong Rhizoma, Trogopteri xanthipes stool, Cyperi Rhizoma,
Corydalis Rhizoma, Artemisiae Scopariae Herba
Pattern of exhaustion of Yin and Yang, and disturbance in spirit
Pulse-Activating Powder
Ginseng Radix Et Rhizoma, Ophiopogonis Radix, Schisandrae
Chinensis Fructus
Xi Jiao Di Huang Decoction
Bubali Cornu, Rehmanniae Radix, Paeoniae Radix Alba or Paeoniae
Radix Rubra, Moutan Cortex
Shen Fu Long Mu Decoction
Ginseng Radix Et RhizomaRubra, Aconiti Lateralis Radix Praeparata,
Astragali Radix, Ostreae Concha, Corni Fructus, Polygonati Rhizoma,
Rehmanniae Radix, Rehmanniae Radix Praeparata, Schisandrae
Chinensis Fructus, Scrophulariae Radix, Ophiopogonis Radix,
Adenophorae Radix
aPericardium refers to an anatomical membrane surrounding heart, and physiologically it protects the heart. When exogenous pathogens invade the heart,
the pericardium is always the ﬁrst to be attacked. Invasion of the pericardium by pathogenic heat gives rise to symptoms of mental disturbances such as coma
and delirium in TCM.
bPhlegm is usually secreted by dysfunction of lung and spleen, and occasionally by the consumption of body ﬂuids by ﬁre and heat evils. A disharmony of
body ﬂuids can produce either external, visible phlegm, such as sputum secreted by the respiratory tract, or internal, invisible phlegm.
cThe Yin-Yang theory believes that the normal life activities of the human body result from the harmonious relation of the unity of opposites between Yin
and Yang. The imbalance between Yin and Yang is one of the basic pathogenesis of a disease. All the pathological changes can be summarized as excess or
deﬁciency of Yin or Yang. To be more concrete, “Yang excess leads to heat syndrome while Yin excess causes cold syndrome”; “Yang deﬁciency results in cold
syndrome while Yin deﬁciency causes heat syndromes”; “Yang deﬁciency aﬀects Yin while Yin deﬁciency aﬀects Yang.”
Rhubarb and Storax Pill [46], Jufang Zhibao Dan [47], Yin
Chen Si Ling Decoction, and Changpu Yujin Decoction [45].
4.1.3. TCM Pattern of HE—Yin Deﬁciency of Liver and
Kidney Coupled with Yang Excess of Liver. The main clinical
manifestation of this syndrome is characterized as follows.
Swarthy complexion, thin shape, faintness, coma, distracted,
jerking movements in the extremities, red and dry tongue
substance with little tongue coating, taut thready or taut
rapid pulse. Treatment should be nourishing liver and
kidney, and expelling wind and heat. TCM prescriptions
commonly used in clinic are Du Xiao Ke Li [49], Yiguan
Decoction [50], Cornu Satgae Decoction, and Subphrenic
Recesses [45].
4.1.4. TCM Pattern of HE—Exhaustion of Yin and Yang
Coupled with Disturbance in Spirit. The main clinical man-
ifestation of this syndrome is characterized as follows.
Dottiness, coma, pale complexion, cold extremities, carphol-
ogy, syncope with convulsion, slow reaction, weak breath,
diaphoresis, incontinence of urine and feces, pale tongue
substance without tongue coating, feeble and impalpable
pulse. Treatment should be supplementing Qi and nour-
ishing Yin, reduce resuscitation, and recuperate depleted
Yang. TCM prescriptions commonly used in clinic are Pulse-
Activating Powder or Cornus Rhinoceri and Rehmanniae
Decoction [51], Shen Fu Long Mu Tang, or Ginseng
Decoction [45].
4.2. TCM Treatmen—Purging Organs and Opening Oriﬁces.
The pathogenesis of HE mostly includes the deﬁciency of
liver and kidney, phlegm retention and blood stasis, failure
of Yang and Yin to raise and fall, respectively, which could be
regarded as the declining function in distributing nutrients
to the organ and excretion out of the organ, leading to the
symptomslikecoma,convulsion,andmentalconfusion[52].
The TCM pattern of the excess phlegm and serum stasis with
the deﬁciency in both Yin and Yang of Qi and blood aﬀect
thementalstability.AclinicalTCMretrospectivesurveywith
a large number of HE patients (n = 1072) and a prospective
survey with 133 HE subjects revealed that the main cause of
liver failure is a combination of toxin, phlegm, and blood
stasis entangled in the body along with dampness, heat,
and pestilence invasion [53]. Therefore, the TCM treatment
approaches involve removing toxin, expelling blood stasis,
and eliminating phlegm have been applied in the clinical
treatment of HE. Several representative clinical studies are
described using this approach in the following.
Rhubarb (Rhei Radix and Rhizoma)i sap o t e n th e r b
with purging activity, which can relieve internal heat and
promote blood circulation by removing blood stasis and
normalizing gallbladder to cure jaundice [54–56]. Li and
Ma [57] applied a decoction of a single medicinal plant,
Rhubarb, through colon infusion in 30 HE patients. About6 Evidence-Based Complementary and Alternative Medicine
30g of Rhubarb was prepared to decoction in a 200mL of
water as an enema. This decoction was administered 1-2
times daily for 10 days as a course of treatment. Six patients
experienced“completeremedy”(CR,deﬁnedasreachingand
maintaining a conscious and lucid state of mind for 3 weeks
after dose), 18 patients experienced “partial remedy” (PR,
signiﬁcant improvement of the symptoms), while 6 patients
had no eﬀect. The total eﬃcacy (CR + PR) was 80%.
L va n dL i[ 58] applied a TCM agent, Tongfu Xiere De-
coction, containing Rhubarb, Dandelion, Magnolia Bark,
Citri Immaturus, and Fructus Mume, to 64 HE patients,
with an attempt to relieve internal heat, and cool, promote
blood ﬂow, and eliminate phlegm and freeing channels. The
patients were divided into two groups, a control group in
which all subjects received intravenous infusion of 40mL of
Qingkailing(aTCMdrug)injection,250mLofBCAAor10g
of Hepa Merz, once a day, and a TCM group in which Tongfu
Xiere Decoction was applied in addition to the treatments in
the control group. The decoction was prepared as an enema
and administered through colon infusion at 250mL a day.
TherapeuticeﬃcacyinTCMgroupreached93.94%whilethe
control group reached 80.65%.
A combined Narcon and Rhubarb therapy for 62 HE
patients was conducted by Huang [59] recently. The patients
were randomly divided into two groups, conventional ther-
apy group (N = 24) with an integrated approach comprising
antibiotics treatment, balancing electrolytes, amino acids,
and pH in body ﬂuid, and so forth, and the treatment
group (N = 38), in which intravenous infusion of Narcon
and colon infusion of Rhubarb decoction were applied in
addition to the approach used in the conventional therapy
group. Narcon was infused at a dose of 4mg in 500mL of
5% Glucose, at 0.3mg/h. The decoction of 30g of Rhubarb
in 500mL water was applied once a day. The results showed
a signiﬁcant improvement in eﬀectiveness in the treatment
group with 94.7% eﬃcacy (deﬁned as showing a conscious
state <48h after dose) compared to an eﬃcacy of 66.7% in
the conventional therapy group.
A similar clinical investigation was conducted using the
decoction of Rhubarb as an enema to treat 60 HE patients
at the First Hospital aﬃliated to Guangxi University of
Traditional Chinese Medicine. The patients were randomly
divided into two groups, conventional therapy group (N =
30) with an integrated approach, and the treatment group
(N = 30) with colon infusion of a decoction of Rhubarb
and Mume Fructus were applied in addition to the approach
used in the conventional therapy group. The decoction of
Rhubarb and Fructus Mume (30g:30g in 100mL water)
was applied once a day. After a 3-day course of treatment,
the total eﬀective rate (deﬁned as HE symptoms improved
by one stage (0–4 stages) within 48h after dose) in the
treatment group was 83.33%, higher than that (56.67%) in
conventional therapy group [60].
5.SummaryandProspect
5.1. Summary of Therapies for HE with Modern Medicine
and TCM. The current diagnoses of HE are still based on
experimentalism lacking accurate and objective evaluation
of the pathology in modern medicine due to the complexity
of the HE pathogenesis. Current treatment of HE is focused
on a comprehensive management of disease symptoms
and improvement of patients’ quality of lives, with less
satisfactory eﬀectiveness in reversing the pathological course
ofHE.Ontheotherhand,long-termexposuretotherapeutic
drugs also results in drug resistance and dependence. As a
result, no universally eﬀective treatment has been generated
in modern medicine. However, the successful use of TCM
therapeutic approaches over the past decades suggests that
alternative approaches be taken into consideration for HE
therapy with holistic and personalized views and a multi-
levelandmultipathwayadjustmentstrategy.Forexample,the
treatment with the strategy of purging organs and removing
blood stasis has been increasingly accepted for HE therapy
in TCM. Nevertheless, more well-designed studies should be
conducted to further evaluate the clinical eﬃcacy of TCM
approaches and elucidate the complicated mechanisms of
TCM treatment for HE patients.
5.2. Prospective. The brain and liver are key targets for
damageinducedbydysregulatedmetabolitesoftenassociated
with gut-generated signals. Thus the gut-liver-brain axis is
crucial for coordinating homeostasis and health. Therefore,
interdisciplinary studies of how dysregulated metabolites
disturb the gut-liver-brain interactions will uncover novel
mechanismsofHE,whichareessentialforunderstandingthe
pathogenesis at a systemic level. Such knowledge is the basis
for development of eﬀectively preventive and therapeutic
strategies in most-at-risk populations.
Recent studies suggest that HE seems to be the result
of the energy metabolism defects in brain, neurotransmitter
abnormity, and mutation of the receptors on the membrane
of neuron. Thus, the pathogenesis of HE might be a result of
systematic dysfunctions in multiple organs. Metabolomics,
an important element for systems biology with genomics,
transcriptomics, and proteomics, has been increasingly
applied in identifying and quantifying signiﬁcantly altered
metabolites in cell, tissue, organ, or organism, as the
end products of biological processes reﬂecting pathological
change of diseases or the eﬀects of medicine to the body.
Serum metabolite proﬁling with 1H-NMR has been imple-
mented in patients with normal, cirrhosis, or minimal HE,
in which substantial diﬀerentiated metabolites have been
identiﬁed among diﬀerent groups [61]. The application of
metabolomics to the study of HE will help understand the
pathogenesis and provide a new method for early diagnosis
of this disease. Metabolomics may be an eﬀective technique
linking quantitative changes of metabolites to syndromes of
TCM because the various syndromes of TCM may result
from global metabolic imbalances in the patients. As a result,
metabolomics can be applied as a holistic proﬁling tool
to unveil the veil of TCM diagnosis and therapies of HE.
Such a novel clinical approach coupled with TCM strategies
is expected to make breakthrough discoveries in the areas
of characterizing metabolic phenotypes of HE, developing
diagnostic and treatment biomarkers, and identifying herbal
medicines suitable for HE treatment.Evidence-Based Complementary and Alternative Medicine 7
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